|
¸¶ÀϽºÅæ¼Ä¡ |
Marketing PM(È£Èí±â,CNS,CV)/À¯¸íÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
10.04 |
|
|
EHN Group |
Á¦¾à.¹ÙÀÌ¿ÀºÎ¹® »ç¾÷°³¹ß °æ·ÂÁ÷ ä¿ë
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
3³â¡è |
ä¿ë½Ã |
08.06 |
|
|
HRKorea |
¹ÙÀÌ¿À»ç¾÷°³¹ß:¹ÙÀÌ¿À½Å¾à ÆÄÆ®³Ê½± ¹ß±¼ ¹× È®º¸(ÇØ¿Ü ¹×
¼¿ï ÀüÁö¿ª | ´ëÇпø(¼®»ç) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
3³â¡è |
ä¿ë½Ã |
06.15 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Sr.PM(BÇü°£¿°Ä¡·áÁ¦)/±¹³»À¯¸íÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
06.25 |
|
|
Ä¿¸®¾îÄɾî |
À¯·´°è Á¦¾àȸ»ç CRA
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
ä¿ë½Ã |
06.25 |
|
|
(ÁÖ)¶ó¿Â¼Ä¡ |
±×·ìÁ¦¾à»ç - ÀÓ»ó°³¹ß(Clinical Development) °æ·ÂÀÚ
°æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
4³â¡è |
ä¿ë½Ã |
07.14 |
|
|
¾Æµ¥ÄÚÄÚ¸®¾Æ |
[±Û·Î¹ú ¿Ü±¹°è]ÀǾàÇ° ¹°·ù¼¾ÅÍ QA Manager
°æ±â ÀÌõ½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
3³â¡è |
ä¿ë½Ã |
05.14 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
Áß°ßÁ¦¾à»ç ¼øȯ±âPM ±¸ÀÎ
Àü±¹ ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
03.19 |
|
|
(ÁÖ)Ä¿¸®¾îºôµå |
¹ýÁ¤ ¼±ÀÓ¾à»ç ¸ðÁýÇÕ´Ï´Ù.
°æ±â ȼº½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
3³â¡è |
ä¿ë½Ã |
07.03 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
Áß¼Ò ÀÇ·á±â±â»ç ÇØ¿Ü¿µ¾÷ °æ·Â»ç¿ø
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¹«¿ª/ÇØ¿Ü¿µ¾÷/Åë¹ø¿ª |
3³â¡è |
ä¿ë½Ã |
02.23 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
´ë±â¾÷ »ýÈ°°Ç° PM ¸ðÁý
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
02.23 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Clinical Research Science(Â÷Àå±Þ)±¹³»MajorÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
ä¿ë½Ã |
06.25 |
|
|
Ä¿¸®¾îÄɾî |
´Ù±¹Àû Á¦¾àȸ»ç _ External Affairs Specialist
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
02.13 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Medical Sales Engineer/¿Ü±¹°èMedicalȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
10.02 |
|
|
À̳ë¼Ä¡ |
¿Ü±¹CRO ÀçÅà RA Manager
Àü±¹ ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
02.04 |
|